Evidence map›Paper›PMID 26492578›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2016

Novel mutations in genes causing hereditary spastic paraplegia and Charcot-Marie-Tooth neuropathy identified by an optimized protocol for homozygosity mapping based on whole-exome sequencing.

Daliya Kancheva, Derek Atkinson, Peter De Rijk, Magdalena Zimon, Teodora Chamova, Vanyo Mitev, Ahmet Yaramis, Gian Maria Fabrizi, Haluk Topaloglu, Ivailo Tournev and 5 more

Erratum issuedOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 39 citations in OpenAlex.

  1. Whole-exome sequencing to analyze population structure, parental inbreeding, and familial linkage.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Trial
  2. Article
  3. Article
  4. Review
  5. Alternative splicing expands the clinical spectrum of NDUFS6-related mitochondrial disorders.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Spastic paraplegia type 46: novel and recurrent GBA2 gene variants in a compound heterozygous Italian patient with spastic ataxia phenotype.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

  • Erratum issued
    Parma, Yesim [corrected to Parman, Yesim]
5 · Who and what money

Authors and funding

15 authors at 8 institutions in 5 countries.

Daliya KanchevaMolecular Neurogenomics Group, Department of Molecular Genetics, VIB, University of Antwerp, Antwerp, Belgium.ORCID 0000-0001-6222-0461
Derek AtkinsonMolecular Neurogenomics Group, Department of Molecular Genetics, VIB, University of Antwerp, Antwerp, Belgium.ORCID 0000-0001-6097-3670
Peter De RijkDepartment of Molecular Genetics, VIB, University of Antwerp, Antwerp, Belgium.ORCID 0000-0001-8558-9288
Magdalena ZimonMolecular Neurogenomics Group, Department of Molecular Genetics, VIB, University of Antwerp, Antwerp, Belgium.ORCID 0000-0001-7255-6639
Teodora ChamovaDepartment of Neurology, Medical University-Sofia, Sofia, Bulgaria.
Vanyo MitevDepartment of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University-Sofia, Sofia, Bulgaria.
Ahmet YaramisDepartment of Pediatrics, Dicle University School of Medicine, Diyarbakir, Turkey.
Gian Maria FabriziDepartment of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Verona, Italy.
Haluk TopalogluDivision of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Ivailo TournevDepartment of Neurology, Medical University-Sofia, Sofia, Bulgaria.
Yesim Parman
Yesim ParmaDepartment of Neurology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
Esra BattalogluDepartment of Molecular Biology and Genetics, Bogazici University, Istanbul, Turkey.
Alejandro Estrada-CuzcanoMolecular Neurogenomics Group, Department of Molecular Genetics, VIB, University of Antwerp, Antwerp, Belgium.ORCID 0000-0001-9868-2465
Albena JordanovaMolecular Neurogenomics Group, Department of Molecular Genetics, VIB, University of Antwerp, Antwerp, Belgium.
University of Antwerp · BEMedical University of Sofia · BGBoğaziçi University · TRDicle University · TRHacettepe University · TRIstanbul University · TRUniversity of Verona · ITVIB-UAntwerp Center for Molecular Neurology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHomozygosity mapping is an effective approach for detecting molecular defects in consanguineous families by delineating stretches of genomic DNA that are identical by descent. Constant developments in next-generation sequencing created possibilities to combine whole-exome sequencing (WES) and homozygosity mapping in a single step.

methodsBasic optimization of homozygosity mapping parameters was performed in a group of families with autosomal-recessive (AR) mutations for which both single-nucleotide polymorphism (SNP) array and WES data were available. We varied the criteria for SNP extraction and PLINK thresholds to estimate their effect on the accuracy of homozygosity mapping based on WES.

resultsOur protocol showed high specificity and sensitivity for homozygosity detection and facilitated the identification of novel mutations in GAN, GBA2, and ZFYVE26 in four families affected by hereditary spastic paraplegia or Charcot-Marie-Tooth disease. Filtering and mapping with optimized parameters was integrated into the HOMWES (homozygosity mapping based on WES analysis) tool in the GenomeComb package for genomic data analysis.

conclusionWe present recommendations for detection of homozygous regions based on WES data and a bioinformatics tool for their identification, which can be widely applied for studying AR disorders.Genet Med 18 6, 600-607.

Indexed as

beta-GlucosidaseCarrier ProteinsCharcot-Marie-Tooth DiseaseChromosome MappingConsanguinityCytoskeletal ProteinsExome SequencingFemaleGlucosylceramidaseHigh-Throughput Nucleotide SequencingHomozygoteHumansMaleMutationPedigreePolymorphism, Single Nucleotidebeta-GlucosidaseCarrier ProteinsCytoskeletal ProteinsGAN protein, humanGBA2 protein, humanGlucosylceramidaseZFYVE26 protein, human

Identifiers

PMID26492578
OpenAlexW2143192293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.